Joseph P. Crowe - Concepedia

Author

Joseph P. Crowe

Also Known As

J Crowe, J P Crowe, J. Crowe, J. P. Crowe, J.P. CROWE, J.P. Crowe, JOSEPH CROWE, Joseph Crowe, Joseph P Crowe, Joseph P. Crowe

130

Publications

6.2K

Citations

H-Index

109

Concepts

All Affiliations

Cleveland Clinic Case Western Reserve University University Hospitals of Cleveland Case Comprehensive Cancer Center Breast Center

About

Joseph P. Crowe is an author at Cleveland Clinic specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	44	3.6K
2	Health Sciences	13	14	920
3	Public Health	4	4	95
4	Engineering	3	3	598
5	Nursing	1	1	14

Joseph P. Crowe

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Diagnosing breast cancer by using Raman spectroscopy Abigail S. Haka, Karen Shafer‐Peltier, Maryann Fitzmaurice, Proceedings of the National Academy of Sciences Human Breast TissueChemical CompositionSpectroscopySurface-enhanced Raman ScatteringBreast Imaging	2005	626
<i>In vivo</i> Margin Assessment during Partial Mastectomy Breast Surgery Using Raman Spectroscopy Abigail S. Haka, Zoya Volynskaya, Joseph A. Gardecki, Cancer Research	2006	419
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Lee P. Adler, Joseph P. Crowe, Nadia Al‐Kaisi, Radiology Positron Emission TomographyBreast OncologyBreast MassesMedical ImagingMedicine	1993	374
Identifying microcalcifications in benign and malignant breast lesions by probing differences in their chemical composition using Raman spectroscopy. Abigail S. Haka, Karen Shafer‐Peltier, Maryann Fitzmaurice, PubMed EngineeringChemical CompositionSurface-enhanced Raman ScatteringPathologyBiomedical Engineering	2002	304
Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis <i>in vivo</i> Karen Shafer‐Peltier, Abigail S. Haka, Maryann Fitzmaurice, Journal of Raman Spectroscopy EngineeringSurface-enhanced Raman ScatteringBiomedical EngineeringOptical CharacterizationCancer Detection	2002	267
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR David G. Hicks, Sarah Short, Nichole Prescott, The American Journal of Surgical Pathology Breast OncologyOncologyCancer EpidemiologyBrain MetastasesBreast Cancer Patients	2006	260
Nipple-Sparing Mastectomy Joseph P. Crowe Archives of Surgery	2004	215
Socioeconomic Factors and Race in Breast Cancer Recurrence and Survival Nahida H. Gordon, Joseph P. Crowe, Jane Brumberg, American Journal of Epidemiology	1992	190
Raman Spectroscopy and Fluorescence Photon Migration for Breast Cancer Diagnosis and Imaging Ramasamy Manoharan, Karen Shafer, Lev T. Perelman, Photochemistry and Photobiology	1998	167
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Breast Cancer Research and Treatment Breast OncologyOncology76-Gene SignatureEndocrine-related CancerMedicine	2008	154

Page 1